Literature DB >> 32110105

Knocking Out SST Gene of BGC823 Gastric Cancer Cell by CRISPR/Cas9 Enhances Migration, Invasion and Expression of SEMA5A and KLF2.

Wei Chen1, Ruixian Ding1, Jinlu Tang1, Haodong Li2, Chonghua Chen2, Yaru Zhang1, Qinxian Zhang1, Xiaoyan Zhu1.   

Abstract

BACKGROUND: The impact and potential molecular mechanisms of SST in the occurrence and development of GC have not been determined.
MATERIALS AND METHODS: Two pairs of sgRNA and reporter were designed according to targeting sequence of SST gene for double-nicking. Plasmids were transfected into 293T for selecting sgRNA with higher cutting efficiency. The subline which has knocked-out SST gene were selected by FACS and verified by sequencing and expression level. Moreover, the migration and invasion ability was evaluated by wound healing and transwell after knocking out SST. Besides, the protein expression of SEMA5A and KLF2 were observed by Western blotting and LSCM. Last, we detected the expression levels of SST, SEMA5A, and KLF2 in GC tissues by Western blotting.
RESULTS: The results revealed that the new subline 1E9, which had knocked out SST gene, was established by CRISPR/Cas9. In addition, the knockout of SST in GC cells markedly increased migration and invasion ability. The results also demonstrated that the knockout of SST increased the expression of SEMA5A and KLF2. The expression level of SST was decreased in GC tissues, and its decrease was associated with overexpression of SEMA5A and KLF2.
CONCLUSION: SST plays an inhibitory role in the migration and invasion of GC cell BGC823. The protein expression levels of SEMA5A and KLF2 were enhanced in GC cells and tissues lacking SST expression.
© 2020 Chen et al.

Entities:  

Keywords:  CRISPR/Cas9; gastric cancer; invasion; migration; somatostatin

Year:  2020        PMID: 32110105      PMCID: PMC7040191          DOI: 10.2147/CMAR.S236374

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


  26 in total

1.  Comparing CRISPR and RNAi-based screening technologies.

Authors:  Benjamin E Housden; Norbert Perrimon
Journal:  Nat Biotechnol       Date:  2016-06-09       Impact factor: 54.908

Review 2.  Mammalian Krüppel-like factors in health and diseases.

Authors:  Beth B McConnell; Vincent W Yang
Journal:  Physiol Rev       Date:  2010-10       Impact factor: 37.312

Review 3.  mTOR Signaling in Growth, Metabolism, and Disease.

Authors:  Robert A Saxton; David M Sabatini
Journal:  Cell       Date:  2017-03-09       Impact factor: 41.582

4.  Differential somatostatin and CXCR4 chemokine receptor expression in MALT-type lymphoma of gastric and extragastric origin.

Authors:  Susann Stollberg; Daniel Kämmerer; Elisa Neubauer; Stefan Schulz; Ingrid Simonitsch-Klupp; Barbara Kiesewetter; Markus Raderer; Amelie Lupp
Journal:  J Cancer Res Clin Oncol       Date:  2016-08-20       Impact factor: 4.553

5.  Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.

Authors:  Christopher J Ricketts; Mark R Morris; Dean Gentle; Michael Brown; Naomi Wake; Emma R Woodward; Noel Clarke; Farida Latif; Eamonn R Maher
Journal:  Epigenetics       Date:  2012-03       Impact factor: 4.528

Review 6.  Hallmarks of cancer: the next generation.

Authors:  Douglas Hanahan; Robert A Weinberg
Journal:  Cell       Date:  2011-03-04       Impact factor: 41.582

7.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

Authors:  Hao Yin; Wen Xue; Sidi Chen; Roman L Bogorad; Eric Benedetti; Markus Grompe; Victor Koteliansky; Phillip A Sharp; Tyler Jacks; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2014-03-30       Impact factor: 54.908

Review 8.  Genome-editing Technologies for Gene and Cell Therapy.

Authors:  Morgan L Maeder; Charles A Gersbach
Journal:  Mol Ther       Date:  2016-01-12       Impact factor: 11.454

9.  Somatostatin signaling via SSTR1 contributes to the quiescence of colon cancer stem cells.

Authors:  Shirin R Modarai; Lynn M Opdenaker; Vignesh Viswanathan; Jeremy Z Fields; Bruce M Boman
Journal:  BMC Cancer       Date:  2016-12-07       Impact factor: 4.430

10.  Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy.

Authors:  S L Parsons; S A Watson; H M Collins; N R Griffin; P A Clarke; R J Steele
Journal:  Br J Cancer       Date:  1998-12       Impact factor: 7.640

View more
  5 in total

Review 1.  CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment.

Authors:  Fatima Akram; Ikram Ul Haq; Sania Sahreen; Narmeen Nasir; Waqas Naseem; Memoona Imitaz; Amna Aqeel
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  Construction of circRNA-miRNA-mRNA network in the pathogenesis of recurrent implantation failure using integrated bioinformatics study.

Authors:  Mohsen Ahmadi; Salar Pashangzadeh; Mahta Moraghebi; Soudabeh Sabetian; Mohammad Shekari; Fatemeh Eini; Ensieh Salehi; Pegah Mousavi
Journal:  J Cell Mol Med       Date:  2021-05-07       Impact factor: 5.310

3.  CD105 expression is associated with invasive capacity in ovarian cancer and promotes invasiveness by inhibiting NDRG1 and regulating the epithelial-mesenchymal transition.

Authors:  Jin Zhang; Xiubo Sang; Rui Zhang; Jingjing Chi; Wenpei Bai
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 4.  Comprehensive Assessment of Somatostatin Receptors in Various Neoplasms: A Systematic Review.

Authors:  Shista Priyadarshini; Derek B Allison; Aman Chauhan
Journal:  Pharmaceutics       Date:  2022-07-01       Impact factor: 6.525

Review 5.  Epigenetic regulation of somatostatin and somatostatin receptors in neuroendocrine tumors and other types of cancer.

Authors:  M J Klomp; S U Dalm; M de Jong; R A Feelders; J Hofland; L J Hofland
Journal:  Rev Endocr Metab Disord       Date:  2020-10-21       Impact factor: 9.306

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.